IntelliCyt Corp. develops and markets innovative products, applications and services for drug discovery and life science research. Using proprietary technologies, the company creates instrumentation, assays, and software products that dramatically increase the speed and decrease the cost of detecting and measuring cells and beads using flow cytometry. IntelliCyt’s product portfolio includes the HTFC™ Screening System, HyperCyt® instrumentation, assay products and services, and informatics software. IntelliCyt’s products address a pressing need among pharmaceutical, biotechnology, and academic research laboratories to achieve increased productivity while adapting to the accelerating pace and increasing complexity of modern life sciences.

CEO: R. Terry Dunlay Contact Info: 317 Commercial NE, Albuquerque, NM 87102 Website: LinkedIn: IntelliCyt on LinkedIn